Remove 2027 Remove Competition Remove Healthcare Provider
article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. However, with rapid growth comes growing pains.

article thumbnail

9 Steps to Build Digital Healthcare Solutions that Meet Patient’s Growing Expectations

PM360

Patients now demand greater access to their health information, desire more communication with their healthcare providers, and seek personalized care tailored to their individual needs. Patients increasingly expect a seamless healthcare experience in which all their health information is integrated and easily accessible.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Successfully Market Your GLP-1 Program: Strategies for Standing Out

LEVO Health

billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Expand Service Offerings Providing a holistic approach to weight management and diabetes care can set your GLP-1 program apart.

article thumbnail

FOCUS ON: Connected TV

PM360

CTV also enables the application of data-driven strategies, allowing healthcare providers to deliver more personalized messaging, versus linear TV, to resonate with consumers. Some of the key advantages of CTV include its cost-effective and targeted approach, making it a more accessible offering for healthcare providers versus linear.

Media 105
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

The downsizing is not a total reversal of Walgreens’ aggressive primary-care clinic expansion plan (which in 2021 imagined 1,000 VillageMD clinics by 2027), but rather a reallocation of capital to increase VillageMD’s density in “high-opportunity” markets—i.e., those with high patient volumes.

Retail 52
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Medical 105